ITRACONAZOLE
| Brand name | TOLSURA |
|---|---|
| Active ingredient | ITRACONAZOLE |
| Strength | 65MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10463740 | June 2033 | product |
| 9713642 | June 2033 | use U-2453 |
| 10806792 | June 2033 | product |
| 8921374 | June 2033 | product |
| 9272046 | June 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.